Ryan Raisner

Ryan Raisner is a Scientist 4 at Genentech, where they have spent the last eight years focusing on novel drug discovery for various cancer indications. Ryan completed a Ph.D. in Biochemistry and Genetics at the University of California, San Francisco, where their doctoral research involved the identification and analysis of negative heterochromatin regulators in *Saccharomyces cerevisiae*. Prior to their current role, Ryan held positions at Bio Architecture Lab and Aurora Algae, Inc., and conducted postdoctoral research at Stanford University, where they worked on targeted gene mutation in zebrafish. They possess extensive skills in various scientific methodologies, including mammalian tissue culture and next-generation sequencing.